Records containing: Unspecified Adult Solid Tumor, Protocol Specific
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-04-25A Phase II Trial of Bevacizumab in Patients With Recurrent Solid Tumor Brain Metastases Who Have Failed Whole Brain Radiation Therapy
-
CLINICAL_TRIALS study record update · 2019-04-22A Pharmacodynamic Study of Sirolimus in Older Children and Adults With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2019-04-16A Phase I Trial of Hydroxychloroquine in Combination With Temsirolimus in Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-04-08Phase I Study of PTK/ZK in Combination With Pemetrexed Disodium (ALIMTA)
-
CLINICAL_TRIALS study record update · 2019-04-08Phase I Trial of The Combination of Vismodegib and Sirolimus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-03-13PHASE I TRIAL OF IRINOTECAN AND TOMUDEX IN COMBINATION ON AN EVERY THREE WEEK SCHEDULE
-
CLINICAL_TRIALS study record update · 2019-03-11Pilot Pharmacokinetic Study of Dose Adjustment of Vinorelbine in Patients With Varying Degree of Liver Dysfunction
-
CLINICAL_TRIALS study record update · 2019-03-01A Phase I Trial of Dabrafenib (BRAFi) and Pazopanib in Patients With BRAF-mutated Advanced Malignant Tumors
-
CLINICAL_TRIALS study record update · 2019-02-28NY-ESO-1 TCR Engineered Adoptive Cell Transfer Therapy With CTLA4 Blockade
-
CLINICAL_TRIALS study record update · 2019-02-22A Phase I Study of Methoxyamine and Temozolomide in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-02-15A Phase I Trial of Stereotactic Radiosurgery for Patients With Hepatic Metastases (SBRT Liver)
-
CLINICAL_TRIALS study record update · 2019-01-11A Phase I Dose Escalation to Maximally Tolerated Dose Trial of 5-Azacytidine (5 AC, NSC 102816) in Combination With Sodium Phenylbutyrate (PB, NSC 657802) in Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-01-04Phase I Study of the Combination of Irinotecan and MLN8237 in Advanced Solid Tumors With Emphasis on Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2018-12-13A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase IIB Study of Oral Naloxone for the Treatment of Opioid-Induced Constipation in Patients With Chronic, Non-malignant Pain or Malignant Pain
-
CLINICAL_TRIALS study record update · 2018-11-08A Placebo Controlled Trial Of Short-Term, High-Dose Epoetin Alfa In Advanced Cancer Outpatients With Mild Fatigue
-
CLINICAL_TRIALS study record update · 2018-10-31The Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Ixabepilone In Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2018-10-26A Phase I/II Study of Taxotere, Oxaliplatin, and 5- Fluorouracil
-
CLINICAL_TRIALS study record update · 2018-10-09A Phase I Scientific Exploratory Study of Epothilone B Analog in Patients With Solid Tumors and Gynecological Malignancies
-
CLINICAL_TRIALS study record update · 2018-10-09The Pilot Palliative ARNP (Advanced Registered Nurse Practitioner) Liaison Program (The PAL Program): Improving Communication Between Patients, Oncologists, and Hospice, Promoting Timely Hospice Referrals and Bringing Education and Research Efforts to Hospice and Palliative Care
-
CLINICAL_TRIALS study record update · 2018-09-10A Phase I Open-Label Safety Study of Escalating Doses of Taxotere in Combination With Escalating Doses of GEM231 in Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-09-10A Phase I Open-Label Safety Study of Escalating Doses of Taxol in Combination With Escalating Doses of GEM231 in Patients With Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-08-29A Phase I and Pharmacokinetic Study of SR-45023A During a 14-Day Treatment Schedule
-
CLINICAL_TRIALS study record update · 2018-08-29A Phase I and Pharmacokinetic Study of SR-45023A Administered Once Every 7 Days
-
CLINICAL_TRIALS study record update · 2018-08-29A Phase I, Pharmacokinetic, and Treatment Duration and Escalation Study of Intravenous Intoplicine Administered as a 5 to 21-Day Continuous Infusion Every 4 Weeks
-
CLINICAL_TRIALS study record update · 2018-08-10High Dose Carboplatin, Etoposide, Cyclophosphamide and Autologous Bone Marrow Transplantation for Relapsed and Refractory Germ Cell Cancer: A Phase II Pilot Study